CODIAK BIOSCIENCES, INC.
35 CambridgePark Drive, Suite 500
Cambridge, MA 02140
November 12, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren S. Hamill
| RE: | Codiak BioSciences, Inc. |
Registration Statement on Form S-3
Filed November 4, 2021
File No. 333-260781
Acceleration Request
Dear Ms. Hamill:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Codiak BioSciences, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Monday, November 15, 2021, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Megan N. Gates of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement.
| Very truly yours, |
| CODIAK BIOSCIENCES, INC. |
/s/ Douglas E. Williams, Ph.D. |
| Douglas E. Williams, Ph.D. |
| Chief Executive Officer |
| cc: | Linda C. Bain, Codiak BioSciences, Inc. |
Yalonda T. Howze, Esq., Codiak BioSciences, Inc.
Megan N. Gates, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
